`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Strategic Intelligence Monitor on Personal Health Systems,
`Phase 2:
`
`Market Developments – Remote Patient Monitoring and
`Treatment, Telecare, Fitness/Wellness and mHealth
`
`Authors: Peter Baum, Fabienne Abadie
`
`
`
`Editors: Fabienne Abadie, Maria Lluch,
`
`Francisco Villanueva Lupiañez, Ioannis Maghiros,
`
`Elena Villalba Mora, Maria Bernarda Zamora Talaya
`
`2 0 1 3
`
`Report EUR 25426 EN
`
`Petitioner Apple Inc. – Ex. 1027, cover p. 1
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`European Commission
`Joint Research Centre
`Institute for Prospective Technological Studies
`
`Contact information
`Address: Edificio Expo. c/ Inca Garcilaso, 3. E-41092 Seville (Spain)
`E-mail: jrc-ipts-secretariat@ec.europa.eu
`Tel.: +34 954488318
`Fax: +34 954488300
`
`http://ipts.jrc.ec.europa.eu
`http://www.jrc.ec.europa.eu
`
`This publication is a Scientific and Policy Report by the Joint Research Centre of the European Commission.
`
`Legal Notice
`Neither the European Commission nor any person acting on behalf of the Commission
`is responsible for the use which might be made of this publication.
`
`Europe Direct is a service to help you find answers to your questions about the European Union
`Freephone number (*): 00 800 6 7 8 9 10 11
`(*) Certain mobile telephone operators do not allow access to 00 800 numbers or these calls may be billed.
`
` A
`
` great deal of additional information on the European Union is available on the Internet.
`It can be accessed through the Europa server http://europa.eu/.
`
`JRC71141
`
`EUR 25426 EN
`
`ISBN 978-92-79-25708-7 (pdf)
`
`ISSN 1831-9424 (online)
`
`doi:10.2791/83417
`
`Luxembourg: Publications Office of the European Union, 2013
`
` ©
`
` European Union, 2013
`
`
`Reproduction is authorised provided the source is acknowledged.
`
`Printed in Spain
`
`Petitioner Apple Inc. – Ex. 1027, cover p. 2
`
`

`

`
`
`Table of Contents
`
`Introduction ............................................................................................................................................... 7
`1.1
`Background .......................................................................................................................................................................... 7
`1.2
`Objectives and approach .............................................................................................................................................. 7
`1.3
`IPHS market segmentation ......................................................................................................................................... 8
`1.4
`Players active on the IPHS market ......................................................................................................................... 9
`1.5
`Definitions ......................................................................................................................................................................... 11
`1.6
`Sources ................................................................................................................................................................................ 13
`1.7
`Structure and content ................................................................................................................................................. 14
`
`The RMT market .................................................................................................................................... 15
`2.1 Market size and potential for growth ................................................................................................................ 15
`2.2 Market players on the RMT segment ................................................................................................................. 19
`2.3
`Has anything changed? .............................................................................................................................................. 19
`2.3.1
`Market analysts’ expectations ..................................................................................................................... 19
`2.3.2
`Scarcity of market data .................................................................................................................................. 20
`2.3.3
`Barriers and drivers ........................................................................................................................................... 21
`2.3.4
`Geographical focus ............................................................................................................................................ 21
`2.3.5
`Type of applications .......................................................................................................................................... 21
`
`The Telecare market ............................................................................................................................ 23
`3.1
`Background ....................................................................................................................................................................... 23
`3.2
`Different generations of Telecare products ................................................................................................... 23
`3.3
`Telecare market data .................................................................................................................................................. 25
`3.4 Market dynamics: recent trends ............................................................................................................................ 29
`3.5
`Barriers and drivers ...................................................................................................................................................... 30
`3.6
`Geographical considerations ................................................................................................................................... 31
`
`1
`
`
`
` 2
`
`
`
` 3
`
` Wellness/fitness and prevention .................................................................................................... 33
`4.1 Wellness/fitness in the IPHS context .................................................................................................................. 33
`4.2 Market data ...................................................................................................................................................................... 34
`4.3 Market dynamics ........................................................................................................................................................... 35
`4.3.1
`The professional market as a hotbed ..................................................................................................... 35
`4.3.2
`Sport enthusiasts as a driver of growth ................................................................................................ 36
`4.3.3
`Corporate fitness: a new niche ................................................................................................................... 37
`
` mHealth .................................................................................................................................................... 39
`5.1 What is mHealth? .......................................................................................................................................................... 39
`5.2
`Overall market developments ................................................................................................................................ 39
`5.3
`Types of services offered ......................................................................................................................................... 40
`5.4
`Smart phone applications as a dynamic emerging field ........................................................................ 41
`5.4.1
`Market trends ........................................................................................................................................................ 41
`5.4.2
`Type of applications offered ........................................................................................................................ 42
`5.4.3
`Market statistics on the emerging apps economy ........................................................................... 44
`5.5 Market size for mHealth in general .................................................................................................................... 47
`5.6
`Actors on the mHealth market ............................................................................................................................... 50
`
` Ecosystem and value chains............................................................................................................. 53
`6.1
`Ecosystem perspective: value chains and business models ................................................................. 53
`6.2
`The role of acquisitions, alliances and industry groups........................................................................... 57
`6.3
`Threats for companies active in the IPHS field ............................................................................................ 58
`
` 4
`
` 5
`
` 6
`
`
`
`1
`
`Petitioner Apple Inc. – Ex. 1027, p. 1
`
`

`

`
`
`7
`
`IPHS market: companies review ...................................................................................................... 59
`7.1
`Geographical spread .................................................................................................................................................... 59
`7.1.1
`Companies characteristics ............................................................................................................................. 60
`7.2
`Product and service characteristics .................................................................................................................... 62
`7.2.1
`Medical focus ........................................................................................................................................................ 62
`7.2.2
`Non-medical focus ............................................................................................................................................. 63
`7.2.3
`Type of products and services offered ................................................................................................... 64
`7.3
`IPHS market positioning ............................................................................................................................................ 66
`
` Concluding remarks ............................................................................................................................. 69
`
` References .............................................................................................................................................. 71
`
` 8
`
` 9
`
`
`Annex 1: Overview of market reports ................................................................................................... 74
`
`Annex 2: Telecare cost data, Spain (2008) .......................................................................................... 77
`
`Annex 3: Companies on the IPHS market ............................................................................................. 78
`3G DOCTORS .................................................................................................................................................................................... 78
`A&D Company, Limited .............................................................................................................................................................. 78
`Abbott .................................................................................................................................................................................................. 78
`Adidas/Reebok ................................................................................................................................................................................. 79
`Aerotel Medical Systems ........................................................................................................................................................... 79
`Aipermon ............................................................................................................................................................................................ 80
`Alive Technologies ........................................................................................................................................................................ 80
`Bayer .................................................................................................................................................................................................... 80
`B. Braun .............................................................................................................................................................................................. 81
`BD (Becton Dickinson and Company) ................................................................................................................................. 81
`Beurer .................................................................................................................................................................................................. 81
`BiancaMed ......................................................................................................................................................................................... 82
`Biotel Inc. /Cardionet ................................................................................................................................................................... 82
`Biotronik ............................................................................................................................................................................................. 83
`Bodymedia Inc ................................................................................................................................................................................ 83
`BodyTel ............................................................................................................................................................................................... 83
`British Telecom (BT) ..................................................................................................................................................................... 84
`Cambridge Silicon Radio (CSR) .............................................................................................................................................. 84
`Cambridge Consultants.............................................................................................................................................................. 85
`Card Guard Group ......................................................................................................................................................................... 85
`Cardiac Science Corporation ................................................................................................................................................... 85
`Cardiocom ......................................................................................................................................................................................... 85
`CAS Medical Systems .................................................................................................................................................................. 86
`CardioMEMS Inc. ............................................................................................................................................................................ 86
`Cardioscan GmbH / Energy Lab Technologies GmbH ............................................................................................... 86
`CareTech ............................................................................................................................................................................................. 87
`Cirrus Communication Systems ............................................................................................................................................ 87
`Cisco ..................................................................................................................................................................................................... 87
`Corscience GmbH .......................................................................................................................................................................... 88
`Custo Med GmbH ........................................................................................................................................................................... 88
`Danmeter A/S .................................................................................................................................................................................. 89
`Deutsche Telekom ........................................................................................................................................................................ 89
`Docobo ................................................................................................................................................................................................ 89
`Dossia .................................................................................................................................................................................................. 90
`Dräger Medical AG & Co ............................................................................................................................................................ 90
`
`2
`
`Petitioner Apple Inc. – Ex. 1027, p. 2
`
`

`

`
`
`Dr. Gerhard Schmidt GmbH ..................................................................................................................................................... 90
`Epocrates ........................................................................................................................................................................................... 90
`ERGO-FIT ............................................................................................................................................................................................ 90
`Fairbanks Scales ............................................................................................................................................................................ 91
`Fitbit ...................................................................................................................................................................................................... 91
`Fold ........................................................................................................................................................................................................ 91
`Fukuda Denshi ................................................................................................................................................................................ 91
`Garmin and Dynastream Innovations ................................................................................................................................ 91
`Google Health .................................................................................................................................................................................. 92
`HeartMath LLC ................................................................................................................................................................................ 92
`High Five Health Promotion ..................................................................................................................................................... 92
`Honeywell Hommed ..................................................................................................................................................................... 93
`Inotive Solutions B.V .................................................................................................................................................................... 93
`Intel ....................................................................................................................................................................................................... 93
`LifeWatch ........................................................................................................................................................................................... 94
`Life Record ........................................................................................................................................................................................ 94
`Lifescan .............................................................................................................................................................................................. 94
`Linde Respiratory Homecare section .................................................................................................................................. 94
`Medtronic ........................................................................................................................................................................................... 95
`Medic4All/Telcomed ..................................................................................................................................................................... 95
`Meigaoy .............................................................................................................................................................................................. 96
`Microlife .............................................................................................................................................................................................. 96
`Microsoft ............................................................................................................................................................................................ 96
`Nihon Kohden .................................................................................................................................................................................. 97
`Nike ....................................................................................................................................................................................................... 97
`Nintendo ............................................................................................................................................................................................. 97
`Nonin .................................................................................................................................................................................................... 97
`Nordic Semiconductor ASA ...................................................................................................................................................... 97
`Orange ................................................................................................................................................................................................. 98
`Omron Healthcare ......................................................................................................................................................................... 99
`Qualcomm ......................................................................................................................................................................................... 99
`OBS Medical ..................................................................................................................................................................................... 99
`OTE ........................................................................................................................................................................................................ 99
`Portugal Telecom .......................................................................................................................................................................... 99
`POLAR Electro ............................................................................................................................................................................... 100
`POWERbreathe ............................................................................................................................................................................. 100
`Philips Healthcare/ PHILIPS DIRECT LIFE ....................................................................................................................... 100
`Preventice ....................................................................................................................................................................................... 101
`Research in Motion's (RIM) .................................................................................................................................................... 101
`Robert Bosch Healthcare ........................................................................................................................................................ 102
`Roche ................................................................................................................................................................................................. 102
`Rossmax .......................................................................................................................................................................................... 103
`RS TechMedic Ltd. (MHealth CVD) .................................................................................................................................... 103
`Sanvartis GmbH .......................................................................................................................................................................... 103
`Schiller .............................................................................................................................................................................................. 103
`Scottcare ......................................................................................................................................................................................... 103
`SHIMMER ......................................................................................................................................................................................... 104
`SenseCore ....................................................................................................................................................................................... 104
`Senslab ............................................................................................................................................................................................. 104
`SHL Telemedicine ....................................................................................................................................................................... 105
`Smiths Medical PM Inc ............................................................................................................................................................ 105
`ST-Ericsson .................................................................................................................................................................................... 105
`St. Jude Medical .......................................................................................................................................................................... 106
`
`3
`
`Petitioner Apple Inc. – Ex. 1027, p. 3
`
`

`

`
`
`STT Condigi .................................................................................................................................................................................... 106
`Sorin ................................................................................................................................................................................................... 106
`Sotera Wireless Inc.................................................................................................................................................................... 106
`Suunto Oy ....................................................................................................................................................................................... 106
`SwissCom........................................................................................................................................................................................ 107
`Tanita ................................................................................................................................................................................................ 107
`TBS Group ....................................................................................................................................................................................... 107
`Telefónica/O2 ............................................................................................................................................................................... 108
`Telekom Austria .......................................................................................................................................................................... 109
`Telecom Italia ............................................................................................................................................................................... 109
`Telenor .............................................................................................................................................................................................. 110
`TeliaSoneria ................................................................................................................................................................................... 110
`Texas Instruments ..................................................................................................................................................................... 110
`Thecarrot.com` ............................................................................................................................................................................ 111
`Tolven................................................................................................................................................................................................ 111
`Transoma ........................................................................................................................................................................................ 111
`Tunstall Healthcare ................................................................................................................................................................... 111
`Tynetec ............................................................................................................................................................................................. 112
`Virgin Health Miles..................................................................................................................................................................... 112
`Vitalograph .................................................................................................................................................................................... 112
`Vitaphone GmbH .......................................................................................................................